1. Home
  2. Clinical Topics
  3. Cardio-Pulmonary
  4. NeoProfen recalled
Cardio-PulmonaryClinical TopicsDrugs and DevicesHealthcare & TechnologyWeb Exclusives

NeoProfen recalled

Share

Lundbeck Inc. has recalled two lots of NeoProfen (ibuprofen lysine) that failed to meet a visible particulate quality requirement. NeoProfen is used to close a clinically significant patent ductus arteriosus (PDA) in premature infants. Read more here.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts